نتائج البحث - "I Shchukin"

1

دورية أكاديمية

Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis ; Влияние фактора Виллебранда на общие патофизиологические механизмы цереброваскулярной патологии и рассеянного склероза

المؤلفون: I. Koltsov A., M. Martynov Yu., A. Yasamanova N., I. Shchukin A., M. Fidler S., A. Boyko N., И. Кольцов А., М. Мартынов Ю., А. Ясаманова Н., И. Щукин А., М. Фидлер С., А. Бойко Н.

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз; 62-68 ; Неврология, нейропсихиатрия, психосоматика; Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз; 62-68 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2021-1S

مصطلحات موضوعية: von Willebrand factor, endothelial dysfunction, cerebrovascular diseases, stroke, multiple sclerosis, фактор Виллебранда, эндотелиальная дисфункция, цереброваскулярные заболевания, инсульт, рассеянный склероз

وصف الملف: application/pdf

العلاقة: https://nnp.ima-press.net/nnp/article/view/1651/1299Test; Wannamethee SG, Whincup PH, Lennon L, et al. Fibrin D-Dimer, Tissue-Type Plasminogen Activator, von Willebrand Factor, and Risk of Incident Stroke in Older Men. Stroke. 2012;43(5):1206-11. doi:10.1161/STROKEAHA.111.636373; Williams SR, Hsu F-C, Keene KL, et al. Genetic Drivers of von Willebrand Factor Levels in an Ischemic Stroke Population and Association With Risk for Recurrent Stroke. Stroke. 2017;48(6):1444-50. doi:10.1161/STROKEAHA.116.015677; Tzoulaki I, Murray GD, Lee AJ, et al. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke – The Edinburgh Artery Study. Circulation. 2007;115(16):2119-27. doi:10.1161/CIRCULATIONAHA.106.635029; Dubchenko E, Ivanov A, Spirina N, et al. Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis. Brain Sci. 2020;10(9):E637. doi:10.3390/brain-sci10090637; Lenting PJ, Casari C, Christophe OD, Denis CV. Von Willebrand factor: the old, the new and the unknown. J Thromb Haemost. 2012;10(12):2428-37. doi:10.1111/jth.12008; Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395-424. doi:10.1146/annurev.biochem.67.1.395; Vischer UM. Von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost. 2006;4(6):1186-93. doi:10.1111/j.1538-7836.2006.01949.x; Wagner D, Olmsted J, Marder V. Immunolocalization of Von-Willebrand Protein in Weibel-Palade Bodies of Human-Endothelial Cells. J Cell Biol. 1982;95(1):355-60. doi:10.1083/jcb.95.1.355; Romani de Wit T, Rondaij MG, Hordijk PL, et al. Real-time imaging of the dynamics and secretory behavior of Weibel-Palade bodies. Arterioscler Thromb Vasc Biol. 2003;23(5):755-61. doi:10.1161/01.ATV.0000069847.72001.E8; Harrison P, Cramer E. Platelet Alpha-Granules. Blood Rev. 1993;7(1):52-62. doi:10.1016/0268-960X(93)90024-X; Veljkovic DK, Cramer EM, Alimardani G, et al. Studies of alpha-granule proteins in cultured human megakaryocytes. Thromb Haemost. 2003;90(5):844-52. doi:10.1160/TH03-02-0125; Lenting PJ, Christophe OD, Denis CV. Von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends. Blood. 2015;125(13):2019-28. doi:10.1182/blood-2014-06-528406; Galbusera M, Zoja C, Donadelli R, et al. Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. Blood. 1997;90(4):1558-64.; Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood. 2008;112(1):11-8. doi:10.1182/blood-2008-02-078170; Zhou WH, Inada M, Lee TP, et al. ADAMTS13 is expressed in hepatic stellate cells. Lab Invest. 2005;85(6):780-8. doi:10.1038/labinvest.3700275; Feys HB, Anderson PJ, Vanhoorelbeke K, et al. Multi-step binding of ADAMTS-13 to von Willebrand factor. J Thromb Haemost. 2009;7(12):2088-95. doi:10.1111/j.1538-7836.2009.03620.x; Muia J, Zhu J, Gupta G, et al. Allosteric activation of ADAMTS13 by von Willebrand factor. Proc Natl Acad Sci U S A. 2014;111(52):18584-9. doi:10.1073/pnas.1413282112; Song J, Chen F, Campos M, et al. Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects. Plos One. 2015;10(8):e0132626. doi:10.1371/journal.pone.0132626; Konkle BA. Von Willebrand Factor and Aging. Semin Thromb Hemost. 2014;40(6):640-4. doi:10.1055/s-0034-1389079; Kokame K, Sakata T, Kokubo Y, Miyata T. Von Willebrand factor-to-ADAMTS13 ratio increases with age in a Japanese population. J Thromb Haemost. 2011;9(7):1426-8. doi:10.1111/j.1538-7836.2011.04333.x; Inoue O, Suzuki-Inoue K, Ozaki Y. Redundant mechanism of platelet adhesion to laminin and collagen under flow – Involvement of von Willebrand factor and glycoprotein Ib-IX-V. J Biol Chem. 2008;283(24):16279-82. doi:10.1074/jbc.C700241200; Rauch A, Wohner N, Christophe OD, et al. On the Versatility of von Willebrand Factor. Mediterr J Hematol Infect Dis. 2013;5(1):e2013046. doi:10.4084/MJHID.2013.046; Bendetowicz AV, Wise RJ, Gilbert GE. Collagen-bound von Willebrand factor has reduced affinity for factor VIII. J Biol Chem. 1999;274(18):12300-7. doi:10.1074/jbc.274.18.12300; Keuren JFW, Magdeleyns EJP, Bennaghmouch A, et al. Microparticles adhere to collagen type I, fibrinogen, von Willebrand factor and surface immobilised platelets at physiological shear rates. Br J Haematol. 2007;138(4):527-33. doi:10.1111/j.1365-2141.2007.06650.x; Reininger AJ. Platelet function under high shear conditions. Hämostaseologie. 2009;29(1):21-4. doi:10.1055/s-0037-1616934; Chen Y, Xiao Y, Lin Z, et al. The Role of Circulating Platelets Microparticles and Platelet Parameters in Acute Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. 2015;24(10):2313-20. doi:10.1016/j.jstroke-cerebrovasdis.2015.06.018; Huang M, Hu Y-Y, Dong X-Q. High concentrations of procoagulant microparticles in the cerebrospinal fluid and peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome. Surg Neurol. 2009;72(5):481-9. doi:10.1016/j.surneu.2008.12.016; Marcos-Ramiro B, Oliva Nacarino P, Serrano-Pertierra E, et al. Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function. BMC Neurosci. 2014;15:110. doi:10.1186/1471-2202-15-110; Jy W, Jimenez JJ, Mauro LM, et al. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost. 2005;3(6):1301-8. doi:10.1111/j.1538-7836.2005.01384.x; Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci. 2005;118(4):771-80. doi:10.1242/jcs.01653; Starke RD, Ferraro F, Paschalaki KE, et al. Endothelial von Willebrand factor regulates angiogenesis. Blood. 2011;117(3):1071-80. doi:10.1182/blood-2010-01-264507; Li Z, Korhonen EA, Merlini A, et al. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS. J Clin Invest. 2020;130(4):1977-90. doi:10.1172/JCI130308; Qin F, Impeduglia T, Schaffer P, Dardik H. Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: Preliminary studies. J Vasc Surg. 2003;37(2):433-9. doi:10.1067/mva.2003.63; Zhang X, Meng H, Blaivas M, et al. Von Willebrand Factor Permeates Small Vessels in CADASIL and Inhibits Smooth Muscle Gene Expression. Transl Stroke Res. 2012;3(1):138-45. doi:10.1007/s12975-011-0112-2; Michaux G, Pullen TJ, Haberichter SL, Cutler DF. P-selectin binds to the D'-D3 domains of von Willebrand factor in WeibelPalade bodies. Blood. 2006;107(10):3922-4. doi:10.1182/blood-2005-09-3635; Denis CV, Andre P, Saffaripour S, Wagner DD. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci USA. 2001;98(7):4072-7. doi:10.1073/pnas.061307098; Gragnano F, Sperlongano S, Golia E, et al. The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy. Mediators Inflamm. 2017;2017:5620314. doi:10.1155/2017/5620314; Khan MM, Motto DG, Lentz SR, Chauhan AK. ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice. J Thromb Haemost. 2012;10(8):1665-71. doi:10.1111/j.1538-7836.2012.04822.x; Pendu R, Terraube V, Christophe OD, et al. P-selectin glycoprotein ligand 1 and beta 2integrins cooperate in the adhesion of leukocytes to von Willebrand factor. Blood. 2006;108(12):3746-52. doi:10.1182/blood-2006-03-010322; Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA. 2010;107(36):15880-5. doi:10.1073/pnas.1005743107; Rondaij MG, Bierings R, Kragt A, et al. Dynamics and Plasticity of Weibel-Palade Bodies in Endothelial Cells. Arterioscler Thromb Vasc Biol. 2006;26(5):1002-7. doi:10.1161/01.ATV.0000209501.56852.6c; Bierings R, van den Biggelaar M, Kragt A, et al. Efficiency of von Willebrand factor-mediated targeting of interleukin-8 into Weibel-Palade bodies. J Thromb Haemost. 2007;5(12):2512-9. doi:10.1111/j.1538-7836.2007.02768.x; Bernardo A, Ball C, Nolasco L, et al. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood. 2004;104(1):100-6. doi:10.1182/blood-2004-01-0107; Knipe L, Meli A, Hewlett L, et al. A revised model for the secretion of tPA and cytokines from cultured endothelial cells. Blood. 2010;116(12):2183-91. doi:10.1182/blood-2010-03-276170; Arumugam TV, Woodruff TM, Lathia JD, et al. Neuroprotection in Stroke by Complement Inhibition and Immunoglobulin Therapy. Neuroscience. 2009;158(3):1074-89. doi:10.1016/j.neuro-science.2008.07.015; Turner NA, Moake J. Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis. Plos One. 2013;8(3):e59372. doi:10.1371/journal.pone.0059372; Feng S, Liang X, Cruz MA, et al. The Interaction between Factor H and Von Willebrand Factor. Plos One. 2013;8(8):e73715. doi:10.1371/journal.pone.0073715; Feng S, Liang X, Kroll MH, et al. Von Willebrand factor is a cofactor in complement regulation. Blood. 2015;125(6):1034-7. doi:10.1182/blood-2014-06-585430; Ingram G, Hakobyan S, Robertson NP, Morgan BP. Complement in multiple sclerosis: its role in disease and potential as a biomarker. Clin Exp Immunol. 2009;155(2):128-39. doi:10.1111/j.1365-2249.2008.03830.x; Zagorac D, Yamaura K, Zhang C, et al. The effect of superoxide anion on autoregulation of cerebral blood flow. Stroke. 2005;36(12):2589-94. doi:10.1161/01.STR.0000189997.84161.95; Chen B, Cheng Q, Yang K, Lyden PD. Thrombin Mediates Severe Neurovascular Injury During Ischemia. Stroke. 2010;41(10):2348-52. doi:10.1161/STROKEAHA.110.584920; Sonneveld MAH, Franco OH, Ikram MA, et al. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality – The Rotterdam Study. Arterioscler Thromb Vasc Biol. 2016;36(12):2446-51. doi:10.1161/ATVBAHA.116.308225; Wieberdink RG, van Schie MC, Koudstaal PJ, et al. High von Willebrand Factor Levels Increase the Risk of Stroke – The Rotterdam Study. Stroke. 2010;41(10):2151-6. doi:10.1161/STROKEAHA.110.586289; Sonneveld MAH, de Maat MPM, Portegies MLP, et al. Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood. 2015;126(25):2739-46. doi:10.1182/blood-2015-05643338; Blann AD, Naqvi T, Waite M, Mccollum CN. Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens. 1993;7(2):107-11.; Brandes RP. Endothelial Dysfunction and Hypertension. Hypertension. 2014;64(5):924-8. doi:10.1161/HYPERTENSIONAHA.114.03575; Frankel DS, Meigs JB, Massaro JM, et al. Von Willebrand Factor, Type 2 Diabetes and Risk of Cardiovascular Disease: The Framingham Offspring Study. Circulation. 2008;118(24):2533-9. doi:10.1161/CIRCULATIONAHA.108.792986; Van Galen KPM, Tuinenburg A, Smeets EM, Schutgens REG. Von Willebrand factor deficiency and atherosclerosis. Blood Rev. 2012;26(5):189-96. doi:10.1016/j.blre.2012.05.002; Gandhi C, Ahmad A, Wilson KM, Chauhan AK. ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF-dependent mechanism. J Thromb Haemost. 2014;12(2):255-60. doi:10.1111/jth.12456; Sonneveld MAH, van Dijk AC, van den Herik EG, et al. Relationship of Von Willebrand Factor with carotid artery and aortic arch calcification in ischemic stroke patients. Atherosclerosis. 2013;230(2):210-5. doi:10.1016/j.atherosclerosis.2013.07.046; Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. Jama-J Am Med Assoc. 1999;282(21):2035-42. doi:10.1001/jama.282.21.2035; Van Agtmaal EL, Bierings R, Dragt BS, et al. The Shear Stress-Induced Transcription Factor KLF2 Affects Dynamics and Angiopoietin-2 Content of Weibel-Palade Bodies. Plos One. 2012;7(6):e38399. doi:10.1371/journal.pone.0038399; Van Thienen JV, Fledderus JO, Dekker RJ, et al. Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization. Cardiovasc Res. 2006;72(2):231-40. doi:10.1016/j.cardiores.2006.07.008; Scridon A, Girerd N, Rugeri L, et al. Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients. Europace. 2013;15(11):1562-6. doi:10.1093/europace/eut121; Conway DSG, Pearce LA, Chin BSP, et al. Plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation – Relationship to stroke risk factors. Circulation. 2002;106(15):1962-7. doi:10.1161/01.CIR.0000033220.97592.9A; Cortes GM, Sandoval MEV, Martinez CAA, et al. Von Willebrand Factor plasma levels variability in nonvalvular Atrial Fibrillation. J Atr Fibrillation. 2014;7(4):99-105. doi:10.4022/jafib.1124; Rewiuk K, Grodzicki T. Correlations of C-reactive protein, von Willebrand factor, and carotid artery intima-media thickness with CHA2DS2-VASc in patients with acute atrial fibrillation. Pol Arch Med Wewn. 2015;125(11):835-44. doi:10.20452/pamw.3162; Kraft P, Drechsler C, Gunreben I, et al. Von Willebrand Factor Regulation in Patients with Acute and Chronic Cerebrovascular Disease: A Pilot, Case-Control Study. Plos One. 2014;9(6):e99851. doi:10.1371/journal.pone.0099851; Lynch JR, Blessing R, White WD, et al. Novel diagnostic test for acute stroke. Stroke. 2004;35(1):57-63. doi:10.1161/01.STR.0000105927.62344.4C; Samai A, Monlezun D, Shaban A, et al. Von Willebrand Factor Drives the Association Between Elevated Factor VIII and Poor Outcomes in Patients With Ischemic Stroke. Stroke. 2014;45(9):2789-91. doi:10.1161/STROKEAHA.114.006394; Hanson E, Jood K, Karlsson S, et al. Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke. J Thromb Haemost. 2011;9(2):275-81. doi:10.1111/j.1538-7836.2010.04134.x; Tobin WO, Kinsella JA, Kavanagh GF, et al. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes. J Neurol Sci. 2017;375:404-10. doi:10.1016/j.jns.2017.02.045; Wiseman S, Marlborough F, Doubal F, et al. Blood Markers of Coagulation, Fibrinolysis, Endothelial Dysfunction and Inflammation in Lacunar Stroke versus Non-Lacunar Stroke and Non-Stroke: Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2014;37(1):64-75. doi:10.1159/000356789; De Meyer SF, Stoll G, Wagner DD, Kleinschnitz C. Von Willebrand Factor an Emerging Target in Stroke Therapy. Stroke. 2012;43(2):599-606. doi:10.1161/STROKEAHA.111.628867; McCabe DJH, Murphy SJX, Starke R, et al. Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke. J Neurol Sci. 2015;348 (1-2):35-40. doi:10.1016/j.jns.2014.10.035; Lambers M, Goldenberg NA, Kenet G, et al. Role of Reduced ADAMTS13 in Arterial Ischemic Stroke: A Pediatric Cohort Study. Ann Neurol. 2013;73(1):58-64. doi:10.1002/ana.23735; Stoll M, Ruehle F, Witten A, et al. Rare Variants in the ADAMTS13 Von Willebrand Factor-Binding Domain Contribute to Pediatric Stroke. Circ-Cardiovasc Genet. 2016;9(4):357-67. doi:10.1161/CIRCGENETICS.115.001184; Bath PMW, Blann A, Smith N, Butterworth RJ. Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome. Platelets. 1998;9(3-4):155-9. doi:10.1080/09537109876618; Zhu X, Cao Y, Wei L, et al. Von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage. Sci Rep. 2016;6:35901. doi:10.1038/srep35901; Гусев ЕИ, Мартынов МЮ, Кольцов ИА и др. Прогностическое значение дисфункции эндотелия и фактора фон Виллебранда в остром и отдаленном периодах геморрагического инсульта полушарной локализации. Журнал неврологии и психиатрии им. C.С. Корсакова. 2019;119(8-2):46-52. doi:10.17116/jnevro201911908246; Boluijt J, Meijers JCM, Rinkel GJE, Vergouwen MDI. Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review. J Cereb Blood Flow Metab. 2015;35(5):724-33. doi:10.1038/jcbfm.2015.13; McGirt MJ, Lynch JR, Blessing R, et al. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;51(5):1128-34. doi:10.1227/01.NEU.0000031751.23324.38; Giovannoni G, Thorpe JW, Kidd D, et al. Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease. J Neurol Neurosurg Psychiatry. 1996;60(1):20-6. doi:10.1136/jnnp.60.1.20; Noubade R, del Rio R, McElvany B, et al. Von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis. Am J Pathol. 2008;173(3):892-900. doi:10.2353/ajpath.2008.080001; Спирин НН, Спирина НН, Бойко АН. Фактор фон Виллебранда и молекулы адгезии у пациентов с рассеянным склерозом. Журнал неврологии и психиатрии им. С.С. Корсакова. 2014;114(2-2):35-9.; Saenz-Cuesta M, Osorio-Querejeta I, Otaegui D. Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us? Front Cell Neurosci. 2014;8:100. doi:10.3389/fncel.2014.00100; Lu K, Liu L, Xu X, et al. ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2020;17(1):67. doi:10.1186/s12974-020-1713-z; Ziliotto N, Bernardi F, Jakimovski D, et al. Hemostasis biomarkers in multiple sclerosis. Eur J Neurol. 2018;25(9):1169-76. doi:10.1111/ene.13681; https://nnp.ima-press.net/nnp/article/view/1651Test

View record in BASE

2

دورية أكاديمية

Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule ; Хемотранскриптомный анализ указывает на нейротрофические и нейромодулирующие эффекты молекулы цитиколина

المؤلفون: I. Torshin Yu., O. Gromova A., L. Stakhovskaya V., V. Semenov A., I. Shchukin A., И. Торшин Ю., О. Громова А., Л. Стаховская В., В. Семенов А., И. Щукин А.

المساهمون: The investigation has been conducted under Russian Foundation for Basic Research Grants No. 20-07-00537 and No. 19-07-00356., Исследование выполнено по теме грантов Российского фонда фундаментальных исследований № 20-07-00537 и № 1907-00356.

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 12, No 4 (2020); 91-99 ; Неврология, нейропсихиатрия, психосоматика; Vol 12, No 4 (2020); 91-99 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2020-4

مصطلحات موضوعية: citicoline, chemotranscriptome analysis, neuroprotection, machine learning, цитиколин, хемотранскриптомный анализ, нейропротекция, машинное обучение

وصف الملف: application/pdf

العلاقة: https://nnp.ima-press.net/nnp/article/view/1420/1103Test; Gimenez R, Raich J, Aguilar J. Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging mice. Br J Pharmacol. 1991 Nov;104(3):575-8. doi:10.1111/j.1476-5381.1991.tb12471.x; Teather LA, Wurtman RJ. Dietary CDPcholine supplementation prevents memory impairment caused by impoverished environmental conditions in rats. Learn Mem. 2005 Jan-Feb;12(1):39-43. doi:10.1101/lm.83905. Epub 2005 Jan 12.; Gareri P, Castagna A, Cotroneo AM, et al. The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study. J Alzheimers Dis. 2017;56(2):557-65. doi:10.3233/JAD-160808; Alvarez-Sabin J, Ortega G, Jacas C, et al. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Cerebrovasc Dis. 2013;35(2):146-54. doi:10.1159/000346602. Epub 2013 Feb 7.; Торшин ИЮ, Громова ОА. Экспертный анализ данных в молекулярной фармакологии. Москва: МЦНМО; 2012. 748 с. ISBN 978-5-4439-0051-3; Katzung BG. Basic and Clinical Pharmacology. 9 th ed. McGraw-Hill Medical; 2003. ISBN 0-07-141092-9; Carvalho FA, Mesquita R, Martins-Silva J, Saldanha C. Acetylcholine and choline effects on erythrocyte nitrite and nitrate levels. J Appl Toxicol. 2004;24(6):419-27. doi:10.1002/jat.993; Cansev M, Yilmaz MS, Ilcol YO, et al. Cardiovascular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous system. Eur J Pharmacol. 2007;577(1-3):129-42. doi:10.1016/j.ejphar.2007.08.029; Torshin IYu. Sensing the change from molecular genetics to personalized medicine. NY (USA): Nova Biomedical Books; 2009. In «Bioinformatics in the Post-Genomic Era» series. ISBN 1-60692-217-0; Торшин ИЮ, Громова ОА, Наумов АВ, Лила АМ. Хемотранскриптомный анализ молекулы глюкозамина сульфата в контексте постгеномной фармакологии. РМЖ. 2019;1(1):2-9.; Торшин ИЮ, Громова ОА, Фролова ДЕ и др. Дозозависимый хемотранскриптомный анализ дифференциального действия витамина D на экспрессию генов в клеткахпредшественниках нейронов npc и в опухолевых клетках MCF7 человека. Фармакокинетика и фармакодинамика. 2018;(2):35-51. doi:10.24411/2587-7836-2018-10013; Torshin IYu, Rudakov KV. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 1: Fundamentals of modern chemical bonding theory and the concept of the chemograph. Pattern Recognit Image Anal. 2014;24(1):11-23. doi:10.1134/S1054661814010209; Torshin IYu, Rudakov KV. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 2: Local completeness of invariants of chemographs in view of the combinatorial theory of solvability. Pattern Recognit Image Anal. 2014;24(2):196-208. doi:10.1134/S1054661814020151; Torshin IYu. The study of the solvability of the genome annotation problem on sets of elementary motifs. Pattern Recognit Image Anal. 2011;21(4):652-62. doi:10.1134/S1054661811040171; Torshin IYu, Rudakov KV. On the procedures of generation of numerical features over partitions of sets of objects in the problem of predicting numerical target variables. Pattern Recognit Image Anal. 2019;29(4):654-67. doi:10.1134/S1054661819040175; Shen XM, Okuno T, Milone M, et al. Mutations causing slow-channel myasthenia reveal that a valine ring in the channel pore of muscle AChR is optimized for stabilizing channel gating. Hum Mutat. 2016 Oct;37(10):1051-9. doi:10.1002/humu.23043. Epub 2016 Aug 21.; Tan-Sindhunata MB, Mathijssen IB, Smit M, et al. Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence. Eur J Hum Genet. 2015 Sep;23(9):1151-7. doi:10.1038/ejhg.2014.273; Tian G, Thomas S, Cowan NJ. Effect of TBCD and its regulatory interactor Arl2 on tubulin and microtubule integrity. Cytoskeleton (Hoboken). 2010 Nov;67(11):706-14. doi:10.1002/cm.20480; Davinelli S, Chiosi F, Di Marco R, et al. Cytoprotective effects of citicoline and homotaurine against glutamate and high glucose neurotoxicity in primary cultured retinal cells. Oxid Med Cell Longev. 2017;2017:2825703. doi:10.1155/2017/2825703. Epub 2017 Oct 15.; Jha NK, Jha SK, Kar R, et al. Nuclear factor-kappa β as a therapeutic target for Alzheimer's disease. J Neurochem. 2019 Jul;150(2):113-37. doi:10.1111/jnc.14687; Brattelid T, Kvingedal AM, Krobert KA, et al. Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i). Naunyn Schmiedebergs Arch Pharmacol. 2004 Jun;369(6):616-28. doi:10.1007/s00210-0040919-4. Epub 2004 Apr 30.; Lee HK, Yeo S, Kim JS, et al. Protein kinase C-eta and phospholipase D2 pathway regulates foam cell formation via regulator of G protein signaling 2. Mol Pharmacol. 2010 Sep;78(3):478-85. doi:10.1124/mol.110.064394. Epub 2010 Jun 17.; https://nnp.ima-press.net/nnp/article/view/1420Test

الإتاحة: https://doi.org/10.14412/2074-2711-2020-4-91-99Test
https://doi.org/10.14412/2074-2711-2020-4Test
https://doi.org/10.1111/j.1476-5381.1991.tb12471.xTest
https://doi.org/10.1101/lm.83905Test
https://doi.org/10.3233/JAD-160808Test
https://doi.org/10.1159/000346602Test
https://doi.org/10.1002/jat.993Test
https://doi.org/10.1016/j.ejphar.2007.08.029Test
https://doi.org/10.24411/2587-7836-2018-10013Test
https://doi.org/10.1134/S1054661814010209Test